ABSTRACT It has been known for some time that dicyclohexylcarbodiimide (DCCD) inhibits the proton translocation function of the cytochrome c oxidase complex (CcO) and that there is one major site in subunit Ill which is modified upon reaction with DCCD (Glu-90 for the bovine enzyme). We have examined the reaction of bovine CcO with N-cyclohexyl-N'-(4-dimethylaminoa-napthyl)carbodiimide (NCD-4), a fluorescent analog of DCCD. NCD-4 labeling of CcO is strongly inhibited by DCCD implicating Glu-90 of subunit III as the site of chemical modification by . The fluorescence of reconstituted NCD-4-labeled bovine CcO is strongly quenched by hydrophobic nitroxides, whereas hydrophilic nitroxides and iodide ions have a reduced quenching ability. It is concluded that the Glu-90 of subunit III resides near the protein-lipid interface of the membrane spanning region of the enzyme. Different quenching abilities of 5-, 7-, 10-, 12-, and 16-4,4-dimethyl-3-oxazolinyloxy-stearic acids suggest that the NCD-4 label is located in the membrane bilayer in the region near the middle of the hydrocarbon tail of stearic acid. In light of these results, it is unlikely that Glu-90 is part of a proton channel that is associated with the proton pumping machinery of the enzyme but the outcome of this study does not eliminate an allosteric regulatory role for this residue.
INTRODUCTION
The cytochrome c oxidase complex (CcO) is the terminal electron transport protein in the mitochondria of eukaryotes and the plasma membrane of some prokaryotes. In mammals, the enzyme is an integral membrane protein consisting of 12-13 different subunits and an assortment of metals including copper, iron, zinc, and magnesium. Although the enzyme exists as a dimer under physiological conditions, the functional unit appears to be the monomer. Each monomer contains four redox active metal centers: two heme A moieties (cytochrome a and cytochrome a3), and two copper ions (CUA and CUB). It is generally agreed that cytochrome a and CUA mediate the electron transfer from ferrocytochrome c to the binuclear center (cytochrome a3 and CUB) where the reduction of dioxygen to water occurs. Subunit I contains the two heme A's and CUB; CUA resides in subunit II.
CcO exploits the sidedness of the membrane to convert part of the redox-free energy of dioxygen reduction into a proton electrochemical gradient across the membrane. It accomplishes this feat in two ways. In the scalar reaction, reducing equivalents from ferrocytochrome c and the protons consumed by the reduction of dioxygen are taken from opposite sides of the membrane. In the vectorial reaction, protons are actively transported against a protonmotive force. It is well established that CcO pumps up to four protons for each molecule of dioxygen reduced hence a stoichiometry of -1 H+/e- (Wikstrom, 1977; Casey et al., 1979a; Sigel and Carafoli, 1980; van Verseveld et al., 1981; Proteau et al., 1983) . From thermodynamic considerations, proton translocation can only result from the last two electron transfers to the binuclear center (Chan and Li, 1990; Babcock and Wikstrom, 1992) . Wikstrom (1989) has confirmed this expected result by showing that the last two electrons cause the pumping of four protons and that the proton translocation ratio for the last two electrons of the dioxygen reduction cycle must be 2 H+/e-. The relaxation of the proton gradient formed by CcO and other proteins in the respiratory chain is coupled to ATP synthesis by the ATP synthase (for reviews see Brunori et al. (1987) , Prochaska and Fink (1987) , Malmstrom (1990) , Saraste (1990) , Kadenbach et al. (1991) , Muller and Azzi (1991) , and Buse and Steffens (1991) ).
In recent years, there has been considerable interest in the molecular mechanism of proton translocation in CcO and the redox linkage involved in this process. Redox linkage refers to the coupling of the downhill electron transfer reaction to the active transport of protons across the osmotic barrier. In direct coupling, the ligands of a redox center become protonated and subsequently deprotonated at some point during the oxidation-reduction cycle of the metal. A number of directly coupled models have been proposed for the mechanism of redox linkage (Babcock and Callahan, 1983; Gelles et al., 1986; Mitchell, 1987 Mitchell, , 1988 Woodruff et al., 1991; Larsen et al., 1992) . Models of indirect coupling also have been proposed (Wikstrom, 1988; Mitchell et al., 1985) . In indirect coupling, the redox state of the metal centers influences the conformational state of the proton translocating elements at some distant location in the protein.
A number of investigators have raised the possibility that some of the indirectly coupled proton translocating elements of the proton pump might reside in subunit III (Casey et al., 1980; Thompson et al., 1985; Prochaska and Reynolds, 1986; Prochaska and Fink, 1987) . It has been known for some time that reaction of the enzyme with DCCD, which modifies Glu-90 of subunit III (bovine numbering), or removal of subunit III by a variety of methods results in inhibited proton translocation (Casey et al., 1979b (Casey et al., , 1980 Azzi et al., 1981 , Prochaska et al., 1981 Brunori et al., 1985; Putter et al., 1985; Sarti et al., 1985; Thelen et al., 1985; Thompson et al., 1985; Finel and Wikstrom, 1986; Prochaska and Reynolds, 1986; Li et al., 1988; Haltia et al., 1991) . There are at least two possible interpretations of these observations. One interpretation is that part or all of the proton translocating elements of the proton pump are located in subunit III. Alternatively, it has been hypothesized that all the proton translocating elements of the pump are located in subunits I and II (Haltia et al., 1991) . In this scenario, subunit III would play a role in modulating the allosteric interactions between subunits I and II in order to accomplish the redox linkage and to vary the proton to electron stoichiometry. The percentage of inhibition of proton translocation by DCCD seems to correlate almost perfectly with the percentage of protein labeled by DCCD (Casey et al., 1980; Prochaska et al., 1981) suggesting that Glu-90 plays at least some role in the mechanism of proton pumping in CcO. However, point mutations of the Paracoccus denitrificans enzyme indicate that Glu-90 is not required for full proton pumping activity (Haltia et al., 1991) . Although deletion of the subunit III gene in P. denitrificans results in decreased cytochrome c oxidizing activity (<5% of wild-type as measured in spheroplasts) (Haltia et al., 1991) and defective assembly of CcO (Haltia et al., 1989 (Haltia et al., , 1991 indicating that subunit III plays an important role in the biogenesis of CcO, identical proton pumping activity is observed in the subunit III deletion mutant further arguing against a role for subunit III in proton translocation (Haltia et al., 1991) . We question this result, however, because the low activity of the mutant enzyme should make turnover comparable to the rate of protonic leaks, thus predicting a noticeable decrease in proton pumping efficiency (i.e., lower respiratory control). In addition, we find it difficult to accept that a defectively assembled enzyme complex should have lower electron transfer activity yet full proton pumping activity.
There exist no data to exclude a regulatory role for subunit III, however; such a regulatory role has been postulated by many investigators (Brunori et al., , 1987 Putter et al., 1985; Sarti et al., 1985; Wikstrom and Casey, 1985; Finel and Wikstrom, 1986; Prochaska and Fink, 1987) . If so, DCCD modification of Glu-90 may modify the tertiary folding of this subunit which in turn may have deleterious effects on its ability to exert control over the redox linkage. The allosteric regulation might even involve Glu-90 more directly if this residue participates in a salt bridge. Such interactions might lead to a lowering of the proton to electron stoichiometry with increasing membrane potential. Since proton to electron ratios are determined by extrapolation to zero membrane potential, it is not surprising that a modulating effect of subunit III has never been reported. In order to better delineate the possibility of subunit III as an allosteric effector, it is first necessary to obtain some idea of the location of Glu-90 within the protein as a whole. This paper describes the use of a fluorescent probe to try to locate Glu-90 of subunit III with respect to the membrane bilayer and the surface of the protein.
A decade ago, Chadwick and Thomas (1983) demonstrated that N-cyclohexyl-N'-(4-dimethylamino-a-napthyl)-carbodiimide (NCD-4) can be used as a fluorescent probe for DCCD binding sites in proteins with their work on the sarcoplasmic reticulum (Ca21 + Mg2+)-ATPase. NCD-4 is a useful probe in that the starting material is nonfluorescent, yet both the protein adduct (an acylurea) and the side product of the reaction (a urea) are fluorescent. These two potential products (see scheme in Fig. 1) are readily distinguished by different fluorescent maxima (Table 1) . Pringle and Taber (1985) have used NCD-4 and a series of spin-labeled stearic acids to show that the major carbodiimide binding site on the mitochondrial proton channel of the bovine FoF, ATPase is fairly deeply buried within the membrane. In this work, Pringle and Taber assumed a 4-6 AO interaction distance for nitroxide quenching of fluorophores (Green et al., 1973) . More recent data by Abrams and London (1992) indicate, however, an interaction distance of 11-15 A for the quenching of fluor- (1983) . NCD-4-acylurea is the adduct with the protein (Fig. 1) ; NCD-4-acetylurea is the model compound formed by reaction of NCD-4 with acetic acid. t Excitation was at 330 nm. § NCD-4 urea proved too insoluble in hexane for spectral measurements. Values in parentheses represent corrected emission maxima. ' 4) = quantum yield.
ophores by spin-labeled lipids. In support of the larger interaction, others have shown that in the case of covalent fluorophore-nitroxide conjugates, the interaction distance for nitroxide quenching is as large as 12 A (Green et al., 1990 ) and significant quenching occurs over a separation distance of up to 20 A (Matko et al., 1990 
MATERIALS AND METHODS Materials
Beef heart CcO was isolated by the method of Hartzell and Beinert (1974) . Enzyme concentrations were determined by using the reduced-minusoxidized difference spectrum at 605 nm (AE'-Ox = 24 mM-1 cm-'). Enzyme preparations were stored at -800C in 25 mM, pH 7.8, K-Phos and 0.5 or 0.1% Brij-35 until ready for use. Native CcO had an activity of -390 s-1 in 10 mM, pH 6.0, K-Phos, 100 mM KCl and 0.05% dodecyl-f3-D-maltoside with an initial ferrocytochrome c concentration of 50 ,tM.
Unless otherwise described below, chemicals were reagent grade, were obtained from commercial suppliers and were used without further purification. NCD-4 and 5-, 7-, and 12-DOXYL-stearic acids were obtained from Molecular Probes; 10-DOXYL-stearic acid and TEMPO were from Aldrich; and 16-DOXYL-stearic acid was from Molecular Probes or Aldrich. Carbonyl cyanide m-chlorophenylhydrozone (CCCP) was obtained from Calbiochem; cytochrome c (type VI), and 4-amino-TEMPO were from Sigma; valinomycin was from Sigma or Calbiochem. Lipids from Sigma were as follows: bovine heart cardiolipin (CL); synthetic dioleoyl L-a-phosphatidylcholine (PC), -99%; and synthetic dioleoyl L-aphosphatidylethanolamine (PE), -99%. Cholic acid (Sigma) was twice recrystallized from water/ethanol (1:1, v/v) and stored at 4°C and pH 7.6 as a 20% stock solution of the potassium salt. DEAE Bio-gel was from Bio-Rad; DE-52 beads were from Whatman, and Sephadex G-25 and G-100 were from Sigma.
Spectroscopic Methods
Optical absorption spectra and kinetic measurements were obtained with an HP8452 diode array UV/Vis spectrophotometer. EPR spectra were recorded using a Varian E-line Century Series X-band spectrometer; protein samples were at liquid nitrogen temperature and spin-labels were at room temperature. Steady-state fluorescence spectra were recorded on an SLM 4800 spectrofluorimeter equipped with a SMC-210 monochromater controller and SE-480-485 electronics (SLM Instruments) which were interfaced to an IBM XT computer. Scattering data were obtained at 900 to a Spectra-Physics series 2000 Argon laser beam (488 nm) using a Malvern System 4700c sub-micron particle analyser interfaced to a Malvern PC 6300.
NCD-4 Modification of CcO
NCD-4-modified CcO (NCD-4-CcO) was prepared as follows. To a 5 ,uM solution of CcO in 10 mM pH 7.4 K-Phos, 0.1% Brij-35 was added a 100-fold molar excess of NCD-4 from a 100 mM ethanol stock solution. The mixture was incubated at 4°C for 18 or 24 h and then centrifuged at 20,000 g for 10 min to remove the precipitated urea. The supernatant was concentrated to about 100 ,iM using Centricon-lOOs (Amicon). The concentrated NCD-4-labeled protein was then applied to a DEAE or DE-52 column equilibrated with 10 mM pH 7.4 K-Phos, 0.1% Brij-35 (low salt). After washing with this buffer (to remove the NCD-4-urea), the salt concentration was increased to 100 mM KCI (high salt) for elution of the protein. The protein was concentrated (as above), diluted to remove 90% of the KCI, and concentrated again, the final concentration being accurately determined using AE'O°x = 24 mM-' cm-'. For the DCCD inhibition experiments, the enzyme was first incubated with a 100-or 500-fold molar excess of DCCD (from a 100 mM ethanol stock solution) for 18 h at 4°C; after the addition of a 100-fold excess of NCD-4, the incubation was continued for another 18 h. Removal of DCCD-and NCD-4-ureas was accomplished by anion exchange chromatography as described above.
NCD-4-labeled subunits were determined by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE). CcO samples were dissociated using 250 mM pH 6.2 Tris-HCl, 8 M urea, 3.3% 2-mercaptoethanol, 5% SDS at room temperature for 1 h and run on a LKB2001 vertical electrophoresis unit using a 7%/0.19% (acrylamide/bisacrylamide) stacking gel, a 14%/0.37% running gel, and a running buffer of 20 mM pH 8.4 Tris-base, 240 mM glycine, and 0.1% SDS. Gels were first photographed under UV illumination to observe the NCD-4 fluorescence; staining with Coomassie Blue allowed identification of the subunits.
Reconstitution of CcO
CcO vesicles (COVs) were formed by the cholate dialysis technique (Hinkle et al., 1972) . PC/PE/CL lipid mixtures (2:2:1, w/w) were brought to near dryness under a stream of nitrogen and residual solvent was removed by vacuum desiccation overnight. The dried lipids were made to a concentration of 25 mg/ml in 93 mM pH 7.4 K-Phos, 1.5% K-Cholate, and sonicated to clarity using a model W-375 tip sonicator from Heat Systems-Ultrasonics, Inc. After cooling for 10 min, 3.5 ml of the sonicated lipids were mixed with CcO and 100 mM pH 7.4 K-Phos to a final volume of 5.0 ml and CcO concentration of 2 tM. The protein-lipid solution was then incubated on ice for 15 min and thereafter centrifuged at 20,000 g for 30 min at 4°C. The supernatant was dialyzed (Spectra/Por 4 tubing; 12-14,000 molecular weight cutoff) for at least 22 h at 40C against 75 volumes of 100 mM pH 7.4 K-Phos with three changes of buffer. After dialysis, the vesicles were centrifuged at 20,000 g for 40 min at 4°C, and the supernatant was stored at 4°C until use.
Respiratory control ratios (RCRs) of the COVs were determined as follows. Cytochrome c stock freshly reduced with sodium dithionite was passed through a 1.5 X 16 cm Sephadex G-25 column equilibrated with 1 mM pH 7.4 K-Phos to remove the excess dithionite. The activity of the COVs was monitored by following the cytochrome c absorption at 550 nm as a function of time after the addition of 4 ,itl vesicles to a 2-ml solution of 40 ,.uM ferrocytochrome c, 8 ,tM CCCP, 7 ,uM valinomycin, and 1 mM pH 7.4 K-Phos in a stirred cuvette. The initial slope was determined and compared with that of an equivalent kinetics run with no ionophores to give the RCR. Typical RCRs for the COVs were between 2 and 3; respiratory control was almost completely lost in the case of the NCD-4-CcO vesicles (NCD-4-COVs). Such low respiratory control was most likely due to leaky vesicles. Light scattering experiments indicate that the vesicles had an average diameter of 40 to 70 nm. No evidence for particles in the 4.5-20-nm range was found thus indicating the absence of CcO in a micellar phase. While respiratory control was poor for these vesicles, it was found necessary to utilize purified synthetic lipids to reduce contaminating fluorescence from impurities found in a more conventional vesicular system. Using semipurified phosphatidylcholine, RCRs > 5 have been obtained using the identical reconstitution procedure.
Fluorescence Quenching
Fluorescence emission spectra of the NCD-4-COVs and COVs were obtained by exciting the sample at 320 nm and scanning from 350 to 550 nm.
All bandwidths were 8 nm. 50-200 ,ul of vesicles were brought to 1 ml with 100 mM pH 7.4 K-Phos and the emission spectra were recorded. Quenchers were added from a stock solution and emission spectra were recorded about 2350 Biophysical Journal NCD-4-Labeled Cytochrome c Oxidase 30 s after the addition of quencher. Difference spectra were computed from the fluorescence of NCD-4-COVs and COVs observed under identical conditions to obtain the NCD-4-CcO fluorescence spectra in the absence or presence of quencher. For comparison of NCD-4 quenching efficiencies, spectra were integrated from 400-550 nm.
Various quenchers were used to obtain information about the labeled residue. For example, quenching by membrane impermeant iodide ions and water-soluble TEMPO nitroxides was used to determine exposure of the residue to the aqueous solvent. Quenching by the more hydrophobic n-DOXYL-stearic acids was used to indicate location of the fluorescent label with respect to the interior of the membrane bilayer. DOXYL-stearic acids labeled with the nitroxide group at varying locations on the fatty acid chain were used to attempt to pinpoint the depth at which the NCD-4 labeled residue was buried within the bilayer. It is assumed that the DOXYL-stearic acids tend to orient themselves perpendicular to the plane of the bilayer with their carboxyl groups anchored at the bilayer-aqueous interface. The stearic acid acting as the most effective quencher is assumed to have the nitroxide positioned nearest the NCD-4 labeled residue.
Spin-labeled stearic acid stock solutions were made approximately 100 mM in ethanol. First derivative EPR spectroscopy was used to determine the relative concentrations of spin-labels in these stock solutions as follows. First derivative EPR spectra were taken of three different aliquots of all stock solutions. Peak to trough heights of the middle band were assumed to be proportional to the concentration of spin-label and an average height was determined for each of the stearic acid stock solutions. The average height over all spin-labels was assumed to correspond to 100 mM, and this intensity was used to determine the concentration of each spin-label stock solution.
We note that in ethanol solution, all of the DOXYL nitroxides used should have similar EPR line widths so the spin concentration can be determined from the height of the central line. 
[
where it is assumed that the volumes are additive, i.e., VT VA + VL.
This result may be rewritten as:
where n = QJJL is the quencher to lipid ratio, L is the amount of lipid in solution (e.g., in milligrams); and [L] = L/VT, i.e., the overall lipid concentration (e.g., in milligrams/ml 
RESULTS

NCD-4 Labeling of CcO
The reaction of NCD-4 with CcO can potentially yield two fluorescent products with overlapping fluorescence spectra, an NCD-4-acylurea and NCD-4-urea (Fig. 1) . According to Chadwick and Thomas (1983) , the quantum yield of fluorescence of NCD-4-urea is about 10 times greater than that of NCD-4-acylurea (adduct with protein-see Table 1 ) and therefore interferes with attempts to monitor quenching of the fluorescence from the labeled protein. This problem is accentuated by the fact that a 100-fold molar excess of NCD-4 is required to obtain sufficient labeling of the protein and this excess results in a great deal of the undesired urea. Some of this NCD-4-urea is easily removed since it has a low (Chadwick and Thomas, 1983; Azzi et al., 1984) . solubility and precipitates out of solution. The remaining NCD-4-urea seems tightly associated with the protein as evidenced by the fact that the residual NCD-4-urea was not removed upon passing the sample through a 1.5 X 15 cm G-100 column. Likewise, there was virtually no loss of the NCD-4-urea upon 16 h dialysis against a 100-fold excess of detergent-buffer (Fig. 2, a-c) .
On the other hand, almost all of the urea can be removed by applying the protein to a DE-52 or DEAE column and washing with about 200 ml of buffer (low salt) before elution (high salt). EPR spectroscopy reveals, however, that a significant amount of CUA is converted to a type-IT-like copper (Li et al., 1988) with this purification procedure (EPR data not shown). Decreasing the volume of the wash buffer to about 50 ml limits the modification of CUA; however, the removal of the NCD-4-urea is incomplete (see Fig. 2, d and e). Interestingly, this remaining NCD-4-urea is lost during the formation of vesicles by cholate dialysis. Reconstitution of NCD-4-CcO without any removal of NCD-4-urea by anion exchange chromatography also yields vesicles devoid of the NCD-4-urea impurity. Thus, the anion exchange chromatography step was either omitted or the NCD-4-CcO was washed with only 50 ml buffer on a DEAE column before reconstitution for use in the fluorescence quenching experiments.
SDS-PAGE indicates that NCD-4 labels predominantly subunit III of CcO (Fig. 3) . A small amount of fluorescence from subunits I and IV was sometimes observed; this phenomenon depended on preparation of enzyme and was not investigated further. The fluorescence from subunit III always appeared much bluer than that from subunits I and IV which was yellowish; this yellowish fluorescence was similar in color to the tryptophan fluorescence observed from the native subunit I. The modification of subunits I and IV by NCD-4 thus appears minimal.
DCCD inhibition of NCD-4 labeling of CcO
Reaction of CcO with DCCD before incubation with NCD-4 results in reduced NCD-4-acylurea fluorescence per mole of protein. Using samples treated identically except for the amount of DCCD added to the solutions, it was determined that a 100-fold excess of DCCD inhibited NCD-4 labeling by about 53%; a 500-fold excess of DCCD inhibited labeling by about 70%. In order to reduce the interfering NCD-4-urea fluorescence, these samples were washed on a DE-52 column with about 200 ml of low salt buffer before elution and the fluorescence spectra were integrated from 400 to 410 nm. SDS-PAGE reveals that NCD-4 labeling of subunit III is inhibited by DCCD (Fig. 3) Thus, the quenching data were fitted to a second degree polynomial. The lipids used for the formation of vesicles were not completely devoid of fluorescent impurities; however, the subtraction of a COV spectrum from an NCD-4-COV spectrum obtained under identical conditions should correct for the contribution of these impurities to the emission spectrum (Fig. 4) . The DOXYL-stearic acids employed in this study contain fluorescence impurities as well, but the simple subtraction procedure used should be sufficient also to eliminate any undesired contribution of these impurities to the emission spectrum. In the case of titration with 7-DOXYL-stearic acid at high lipid concentrations, however, subtraction of a COV spectrum from an NCD-4-COV spectrum obtained under identical conditions apparently did not suffice to isolate the NCD-4 emission. The fluorescence maximum in the quenching of NCD-4 fluorescence with 7-DOXYL-stearic acid at [L] = 3.50 mg/ml (as analyzed by the subtraction procedure described) was blue-shifted -7 nm and the fluorescence peak became distorted toward the red (data not shown). Accordingly, the 7-DOXYL-stearic acid quenching data for [L] = 3.50 mg/ml were not included in the analysis.
A representative plot summarizing the fluorescence quenching of NCD-4-COVs by the DOXYL-stearic acids is shown in Fig. 5 A. The data represent quenching by 12-DOXYL-stearic acid at four different lipid (vesicle) concentrations. For each lipid concentration, the data were fitted to a second degree polynomial. Using these best fit curves, the DOXYL-stearic acid concentration that yielded a given FO/F were estimated for each of the four lipid concentrations studied. The result is the family of curves shown in Fig. 5 B, where the total quencher concentration required to achieve a given quenching level is plotted against the four lipid concentrations. According to Eq. 3, the y-intercept of each of these curves ( (Fig. 6) and FO/F vs. [Q]L (Fig. 7) . In each case, the identical conclusion is reached regarding the location of the NCD-4 probe vis-'a-vis the bilayer membrane and the surface of the protein, namely, that the NCD-4 label is located near carbon positions 7-10 of stearic acid. As controls, the quenching of NCD-4-COVs by KI as well as by two water soluble nitroxides, TEMPO and 4-amino-TEMPO, was also studied. Results from these experiments are summarized in Fig. 8 . As expected, the most hydrophobic of the soluble nitroxides (TEMPO) proved to be the most effective quencher and KI was the least effective in quenching of the NCD-4 fluorescence. It may seem somewhat surprising that KI is a more effective quencher of NCD-4-acetylurea in dodecyl-p3-D-maltoside micelles rather than in free solution (20% ethanol solution) for one expects the hydrophobic model compound to partition preferentially into the micelle (Fig. 8 B) . One should be reminded, however, that the sugar moieties of the detergent molecules have a high affinity for iodide ions and hence act to increase the local concentration of the quencher ion. In any case, the KI quenching of NCD-4-acetylurea in dodecyl-,B-D-maltoside micelles clearly establishes iodide as an effective quencher for the fluorophore in question. Upon comparison of [Q]TS necessary to yield a given quenching efficiency, it is clear that the DOXYL-stearic acids were more effective in quenching the NCD-4-CcO fluorescence than the TEMPO nitroxides by about one order of magnitude. Note the dif- ferent abscissa scales for the DOXYL (Fig. 5 A) , TEMPO ( Fig. 8 A) and the heavy atom quenchers (Fig. 8 B) . These results are consistent with the conclusions derived from the DOXYL-stearic acid quenching experiments that the NCD-4 probe in the modified CcO resides at or close to the surface of the protein in the hydrophobic region exposed to the membrane bilayer.
DISCUSSION
Reaction of NCD-4 with CcO N-(2,2,6,6-Tetramethylpiperidyl-1-oxyl)-N' -cyclohexylcarbodiimide (NCCD), a spin-label analog of DCCD, appears to modify CcO at the DCCD site (Casey et al., 1981a,b) , suggesting that NCD-4 would label also at this site. The inhibition of NCD-4 labeling of the enzyme by DCCD confirms this expectation.
In the course of these experiments, it was found that fairly harsh conditions (anion exchange chromatography which tends to modify CcO) were necessary to completely isolate the fluorescently labeled protein from the NCD-4-urea sideproduct. According to Chadwick and Thomas (1983) , the fluorescence maximum of NCD-4-urea can be an effective indicator of the solvent dielectric in the immediate vicinity of this side product. These investigators have reported that NCD-4-urea has a fluorescence maximum at about 460 nm in pure ethanol and at about 473 nm in 50% ethanol (Table  1 ). The Amax of 445 nm observed for the fluorescence emission of the bound NCD-4-urea (Fig. 2 d) indicates that the bound NCD-4-urea must be located in a fairly hydrophobic environment (E < 10).
Glu-90 Resides in a Hydrophobic Environment Previous work by Casey and co-workers (1981a,b) on NCCD-labeled CcO indicates that the DCCD binding site is fairly apolar. The present study provides two lines of evidence in support of this conclusion. First, the Amax of the fluorescence emission by NCD-4-CcO is consistent with the idea that the NCD-4 probe is located in a hydrophobic environment. Second, the apolar location of the NCD-4 probe is confirmed by the effective quenching of the NCD-4 fluorescence by DOXYL-stearic acids that partition preferentially into the bilayer membrane.
The fluorescence spectrum of NCD-4-CcO reveals that the DCCD-binding site is not exposed to the aqueous solvent. In this study, the fluorescence maximum of NCD-4-CcO never exceeded 425 nm. Chadwick and Thomas (1983) have reported a fluorescence maximum for N-acetylurea of about 398 nm in hexane, 425 nm in ethanol, and 440 nm in 50% ethanol (Table 1) . In our hands, the NCD-4-acetylurea model compound has a fluorescence maximum of about 420 nm in dodecyl-3-D-maltoside micelles and 440 nm in 20% ethanol (data not shown). It thus appears that the NCD-4 probe is located in a fairly hydrophobic environment. Interestingly, the detergent (Brij-35) solubilized NCD-4-CcO exhibits a fluorescence maximum at about 405 nm (Fig. 2) , though the maximum is around 425 nm (Fig. 4) It is clear that the different effectiveness of the DOXYLstearic acids, the TEMPO derivatives and KI in quenching the fluorescence of NCD-4-COVs indicates that the NCD-4 probe is located in a hydrophobic environment. Our aim in using the various DOXYL-stearic acids was to pinpoint the depth at which NCD-4 is embedded within the membrane bilayer. While none of the DOXYL derivatives used is clearly the most effective quencher, the data suggests that the NCD-4 probe resides at a membrane depth near the middle of the hydrocarbon chain of stearic acid in the region near carbon positions [7] [8] [9] [10] (Figs. 6 and 7) . Our data indicate that 16-DOXYL-stearic acid was the least effective DOXYL quencher. If we assume that the probe is not located in the central region of the membrane (11-16-carbon region of stearic acid) as our data suggest, then the distance between quencher planes of the two leaflets is >10-12 A. This distance is basically the critical interaction distance indicating that quenching from the opposite leaflet is most likely insignificant. A calculation using the "parallax" method (Abrams and London, 1992) as it has been known for some time that the ligand structure of CUA in subunit II becomes unstable upon subunit IIIdepletion (Li et al., 1988) . Moreover, subunit III could serve as an allosteric effector and modulate the allosteric interactions between subunits I and II that are expected to be obligatory for redox linkage. One scenario is that these allosteric interactions can be tuned by subunit III to allow modulation of the proton to electron stoichiometry as a function of membrane potential. Since two protons are pumped per electron for the last two electrons of a turnover cycle (Wikstrom, 1989) , it is possible that one proton is pumped in a directly coupled fashion and the second proton is linked to (a) redox center(s) in an indirect fashion (Chan and Li, 1990 (Fig. 9) . CONCLUSIONS 1. In light of these fluorescence results, we conclude that the Glu-90 of subunit III resides near the protein-lipid interface of the membrane spanning region of the enzyme. A proton channel through the protein is expected to be inaccessible from the lipid bilayer and confined, allowing passage of molecules no larger than H30+. Since the interaction distance for fluorescence quenching by nitroxides is 11-15 A (Abrams and London, 1992) and the diameter of a transmembrane helix is .10 A, it is evident from our results that Glu-90 could be on the interior side of a helix in contact with the lipid bilayer. This situation would allow Glu-90 to be part of a proton channel through the protein. However, the reaction of diimides with Glu-90 would likely disrupt the helix-helix packing and/or reorient the membrane helices to accommodate the bulky label. As there is no experimental evidence for such a major conformational change upon reaction of the enzyme with DCCD or NCD-4, we prefer a scenario in which Glu-90 is exposed to the lipid milieu. If this is the case, Glu-90 is unlikely to be an element of a proton channel associated with the proton pumping machinery of the enzyme. Our results agree with the mutagenesis results of Haltia et al. (1989) which showed that that Glu-90 is not an element of a proton channel and with previous work that established that the DCCD binding site resides in a hydrophobic environment (Casey et al., 1981a,b) . However, this is the first study that attempts to three-dimensionally locate Glu-90 and we experimentally validate the placement of Glu-90 in a transmembrane helix based on hydropathy plots (Fig. 9) . In addition, we show that Glu-90 is a surface or near-surface residue exposed to the lipid environment. 2. This is the first study utilizing the fluorescence probe NCD-4 to examine the DCCD binding site. It was found that the emission maxima for the detergent-solubilized and reconstituted NCD-4 labeled protein were different likely indicating different conformations in a micellar and bilayer environment. Such conformational modifications may be a consequence of the important role of phospholipids (especially cardiolipin) in enzyme turnover (Abramovitch et al., 1990; Robinson et al., 1990) .
3. This is the first report providing evidence for a binding site for a sideproduct of incubation with carbodiimides (in this case, NCD-4-urea). It is likely that NCD-4-urea binds nonspecifically to hydrophobic regions of the enzyme. On the other hand, NCD-4-urea may bind more specifically suggesting a binding site for dicyclohexylurea which may be responsible, in part, for the reduced proton pumping ability of the DCCD treated enzyme. Additional support for this hypothesis comes from the work of Lehninger and coworkers (1985) . These investigators found that the proton pumping activity of CcO is partially inhibited immediately after addition of DCCD presumably before the enzyme is modified by DCCD at Glu-90 of subunit III suggesting that hydrophobic binding of DCCD may inhibit proton pumping activity. 4. Finally, a novel methodology for interpreting fluorescence quenching results using stearic acid nitroxides is presented. In contrast to previous studies, the resolution of the technique appears poor. This is not due to any theoretical difficulties, but rather arises from the large size of the fluorophore utilized and the large conformational space sampled by the fluorophore. Our conclusion that the NCD-4 probe resides near the protein-lipid interface of the membrane spanning region of the enzyme is firm, however, based on the quenching abilities of water soluble TEMPO derivatives and KI.
